The Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) conference 2019 is supported by various educational supporters.
The session entitled “HIV and HCV: How far have we come and where are we going?” is supported by sponsorship from Gilead Sciences.
The session entitled “At the forefront of treatment: challenges and innovations” is supported by sponsorship from Camurus AB.
The IOTOD satellite session on use of medical cannabis is supported by grant funding from Althea Life.
The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and conference organiser.